| Dr Thomas Jerome Wilson, MD | |
|
500 Riverview Ave, Waukesha, WI 53188-3632 | |
| (262) 548-7666 | |
| (262) 548-7656 |
| Full Name | Dr Thomas Jerome Wilson |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 500 Riverview Ave, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043369200 | NPI | - | NPPES |
| 30153500 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 21107 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Jerome Wilson, MD 500 Riverview Ave, Waukesha, WI 53188-3632 Ph: (262) 548-7666 | Dr Thomas Jerome Wilson, MD 500 Riverview Ave, Waukesha, WI 53188-3632 Ph: (262) 548-7666 |
News Archive
MAP Pharmaceuticals, Inc. today announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic absorption of LEVADEX was not higher and systemic exposure to DHE was not greater in smokers than in non-smokers.
News outlets report on how a range of health law provisions are taking shape, including the proposed rule on federal subsidies to buy insurance, Medicaid expansion and accountable care organizations.
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are investigating if a medication used to regulate blood sugar can alter motivation to use alcohol by targeting the brain's stress response system.
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration, is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.
Insomnia is linked to frequency of alcohol use among early adolescents, according to new Rutgers University-Camden research.
› Verified 9 days ago
Dr. Malti Mahendra Patel, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 514 Riverview Ave, Waukesha, WI 53188 Phone: 262-548-7665 Fax: 262-970-6696 | |
Paul Larson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 721 American Avenue Suite 501, Phc Behavioral Medicine Center, Waukesha, WI 53188 Phone: 262-928-2396 Fax: 262-544-1213 | |
Randall B Steinhaus, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 721 American Ave, Suite 501, Waukesha, WI 53188 Phone: 262-928-2396 | |
Dr. Stanya Smith, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1111 Delafield St Ste 105, Waukesha, WI 53188 Phone: 262-542-9503 Fax: 262-542-8447 | |
Gobind Kang-chahal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 514 Riverview Ave, Waukesha, WI 53188 Phone: 262-548-7666 | |
Dr. Matthew R Herald, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 721 American Ave Ste 501, Waukesha, WI 53188 Phone: 262-928-7528 Fax: 262-928-5096 |